Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label comparison of initial HIV antiretroviral regimens containing Truvada
ACTRN12610001098022Phase 4Active, not recruiting
- Sponsor
- The Kirby Institute
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 4, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Truvada + Stocrin, Truvada + ritonavir + atazanavir and Truvada + zidovudine + abacavir (3 arms). Primary endpoint: Time-weighted mean change from baseline plasma HIV RNA. Started Feb 2007; status: active, not recruiting.
02
Drugs
emtricitabine + tenofovir disoproxilefavirenzritonaviratazanavirzidovudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ACTRN12610001098022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001098022.